Precigen, Inc
Clinical trials sponsored by Precigen, Inc, explained in plain language.
-
New combo therapy aims to revive immune attack on hard-to-treat cervical cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (PRGN-2009) to the existing immunotherapy pembrolizumab can shrink tumors in people with advanced cervical cancer that no longer responds to pembrolizumab alone. About 24 adults with HPV-positive, recurrent or metastatic cervic…
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 26, 2026 09:29 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis study tests whether retreating adults with recurrent respiratory papillomatosis (RRP) with a gene therapy called Zopapogene imadenovec can reduce the need for repeated surgeries to remove throat growths. It involves 30 participants in two groups: one to check how the virus v…
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 26, 2026 09:28 UTC